SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain - PubMed (original) (raw)
SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain
Li-Qing Jin et al. J Neurochem. 2003 Apr.
Free article
Abstract
Previously a distinct D1-like dopamine receptor (DAR) that selectively couples to phospholipase C/phosphatidylinositol (PLC/PI) was proposed. However, lack of a selective agonist has limited efforts aimed at characterizing this receptor. We characterized the in vitro and in vivo effects of SKF83959 in regulating PI metabolism. SKF83959 stimulates (EC50, 8 micro m) phosphatidylinositol 4,5-biphosphate hydrolysis in membranes of frontal cortex (FC) but not in membranes from PC12 cells expressing classical D1A DARs. Stimulation of FC PI metabolism was attenuated by the D1 antagonist, SCH23390, indicating that SKF83959 activates a D1-like DAR. The PI-linked DAR is located in hippocampus, cerebellum, striatum and FC. Most significantly, administration of SKF83959 induced accumulations of IP3 in striatum and hippocampus. In contrast to other D1 DAR agonists, SKF83959 did not increase cAMP production in brain or in D1A DAR-expressing PC12 cell membranes. However, SKF83959 inhibited cAMP elevation elicited by the D1A DAR agonist, SKF81297, indicating that the compound is an antagonist of the classical D1A DAR. Lastly, we demonstrated that SKF83959 enhances [35S]guanosine 5'-O-(3-thiotriphosphate) binding to membrane Galphaq and Galphai proteins, suggesting that PI stimulation is mediated by activation of these guanine nucleotide-binding regulatory proteins. Results indicate that SKF83959 is a selective agonist for the PI-linked D1-like DAR, providing a unique tool for investigating the functions of this brain D1 DAR subtype.
Similar articles
- Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions.
Jin LQ, Wang HY, Friedman E. Jin LQ, et al. J Neurochem. 2001 Sep;78(5):981-90. doi: 10.1046/j.1471-4159.2001.00470.x. J Neurochem. 2001. PMID: 11553672 - SKF83959 exhibits biochemical agonism by stimulating [(35)S]GTP gamma S binding and phosphoinositide hydrolysis in rat and monkey brain.
Panchalingam S, Undie AS. Panchalingam S, et al. Neuropharmacology. 2001 May;40(6):826-37. doi: 10.1016/s0028-3908(01)00011-9. Neuropharmacology. 2001. PMID: 11369036 - The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959.
Zhen X, Goswami S, Friedman E. Zhen X, et al. Pharmacol Biochem Behav. 2005 Apr;80(4):597-601. doi: 10.1016/j.pbb.2005.01.016. Pharmacol Biochem Behav. 2005. PMID: 15820529 - Dopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role?
Lee SM, Yang Y, Mailman RB. Lee SM, et al. J Pharmacol Exp Ther. 2014 Oct;351(1):9-17. doi: 10.1124/jpet.114.214411. Epub 2014 Jul 22. J Pharmacol Exp Ther. 2014. PMID: 25052835 Free PMC article. Review. - Dopamine D1 receptor regulation of phospholipase C.
Jose PA, Yu PY, Yamaguchi I, Eisner GM, Mouradian MM, Felder CC, Felder RA. Jose PA, et al. Hypertens Res. 1995 Jun;18 Suppl 1:S39-42. doi: 10.1291/hypres.18.supplementi_s39. Hypertens Res. 1995. PMID: 8529072 Review.
Cited by
- Reversal of quinpirole inhibition of ventral tegmental area neurons is linked to the phosphatidylinositol system and is induced by agonists linked to G(q).
Nimitvilai S, McElvain MA, Arora DS, Brodie MS. Nimitvilai S, et al. J Neurophysiol. 2012 Jul;108(1):263-74. doi: 10.1152/jn.01137.2011. Epub 2012 Apr 4. J Neurophysiol. 2012. PMID: 22490559 Free PMC article. - Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats.
Perreault ML, Hasbi A, Alijaniaram M, O'Dowd BF, George SR. Perreault ML, et al. Neuroscience. 2012 Dec 6;225:130-9. doi: 10.1016/j.neuroscience.2012.08.042. Epub 2012 Sep 15. Neuroscience. 2012. PMID: 22986162 Free PMC article. - Inhibitory effects of dopamine on spinal synaptic transmission via dopamine D1-like receptors in neonatal rats.
Kawamoto K, Otsuguro K, Ishizuka M, Ito S. Kawamoto K, et al. Br J Pharmacol. 2012 May;166(2):788-800. doi: 10.1111/j.1476-5381.2011.01815.x. Br J Pharmacol. 2012. PMID: 22168428 Free PMC article. - Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.
Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV. Goldman-Rakic PS, et al. Psychopharmacology (Berl). 2004 Jun;174(1):3-16. doi: 10.1007/s00213-004-1793-y. Epub 2004 Apr 30. Psychopharmacology (Berl). 2004. PMID: 15118803 Review. - The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.
Shen MY, Perreault ML, Fan T, George SR. Shen MY, et al. Pharmacol Biochem Behav. 2015 Jan;128:33-40. doi: 10.1016/j.pbb.2014.11.011. Epub 2014 Nov 13. Pharmacol Biochem Behav. 2015. PMID: 25444866 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous